PKM and lip and oral cavity carcinoma: Oncometabolites such as SAICAR have been found to support the growth and invasiveness of oral cancer cells by targeting PKM2, with specific binding sites within the activator site of PKM2 identified as GLY321, ARG436, HIS439, LYS266, and TYR466 [54].